1 – 36 of 36
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort
2024) In Journal of Neurology(
- Contribution to journal › Article
-
Mark
A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings
(
- Contribution to journal › Article
-
Mark
Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment
(
- Contribution to journal › Article
-
Mark
Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter Microstructure
2024) In Annals of Clinical and Translational Neurology(
- Contribution to journal › Article
-
Mark
Investigating reliable amyloid accumulation in Centiloids : Results from the AMYPAD Prognostic and Natural History Study
(
- Contribution to journal › Article
-
Mark
Amyloid-PET imaging predicts functional decline in clinically normal individuals
(
- Contribution to journal › Article
-
Mark
European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders
(
- Contribution to journal › Scientific review
- 2023
-
Mark
Impact of simulated reduced injected dose on the assessment of amyloid PET scans
2023) In European Journal of Nuclear Medicine and Molecular Imaging(
- Contribution to journal › Article
-
Mark
Recruitment of pre-dementia participants : main enrollment barriers in a longitudinal amyloid-PET study
(
- Contribution to journal › Article
-
Mark
European consensus for the diagnosis of MCI and mild dementia : Preparatory phase
(
- Contribution to journal › Article
-
Mark
Dementia prevention in memory clinics : recommendations from the European task force for brain health services
(
- Contribution to journal › Scientific review
- 2022
-
Mark
The probabilistic model of Alzheimer disease : the amyloid hypothesis revised
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Management of Alzheimer's disease takes a leap forward
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework
(
- Contribution to journal › Scientific review
-
Mark
The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers : methodological update
(
- Contribution to journal › Article
- 2020
-
Mark
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Applying the ATN scheme in a memory clinic population : The ABIDE project
(
- Contribution to journal › Article
-
Mark
Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment : the effect of age at onset
(
- Contribution to journal › Article
-
Mark
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE) : a modelling study
(
- Contribution to journal › Article
- 2018
-
Mark
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia
(
- Contribution to journal › Article
-
Mark
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
(
- Contribution to journal › Article
- 2017
-
Mark
Preclinical effects of APOE ϵ4 on cerebrospinal fluid Aβ42 concentrations
(
- Contribution to journal › Article
-
Mark
Association between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals : A Longitudinal Descriptive Cohort Study
(
- Contribution to journal › Article
-
Mark
The frequency and influence of dementia risk factors in prodromal Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
(
- Contribution to journal › Scientific review
-
Mark
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes
(
- Contribution to journal › Article
- 2015
-
Mark
Predicting Progression from Cognitive Impairment to Alzheimer's Disease with the Disease State Index
(
- Contribution to journal › Article
-
Mark
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
(
- Contribution to journal › Article
-
Mark
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
(
- Contribution to journal › Article
-
Mark
The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey.
(
- Contribution to journal › Article
-
Mark
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
(
- Contribution to journal › Article
- 2014
-
Mark
Automatic temporal lobe atrophy assessment in prodromal AD: Data from the DESCRIPA study
(
- Contribution to journal › Article
- 2013
-
Mark
Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
(
- Contribution to journal › Article
-
Mark
Single-Domain Amnestic Mild Cognitive Impairment Identified by Cluster Analysis Predicts Alzheimer's Disease in the European Prospective DESCRIPA Study
(
- Contribution to journal › Article
-
Mark
The Association Between APOE epsilon 4 and Alzheimer-type Dementia Among Memory Clinic Patients is Confined to those with a Higher Education. The DESCRIPA Study
(
- Contribution to journal › Article
- 2012
-
Mark
The association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent
(
- Contribution to journal › Article